---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-005361"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2021-11-09T23:59:59+00:00"
generated_at: "2026-06-28T10:33:38.997687+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Sonoma signs 20-year exclusive license & distribution deal with Dyamed for four Southeast Asian markets

## Summary
- Exclusive rights for hypochlorous acid products (dermatology, eye, oral) in Singapore, Malaysia, Indonesia, and Thailand.
- 20-year term; Dyamed pays royalty and transfer prices (amounts redacted).
- Minimum annual purchase commitments in USD for first 10 years (redacted).
- Exclusive license to use Sonoma's Microcyn trademark in the Territory.
- Dyamed responsible for regulatory approvals, marketing, and distribution at its own cost.

## SEC filing metadata
- accession: 0001683168-21-005361
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2021-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316821005361/0001683168-21-005361-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316821005361/snoa_i8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-005361
- JSON: https://secwatch.observer/filing/0001683168-21-005361.json
- Plain text: https://secwatch.observer/filing/0001683168-21-005361.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.